Modulation of inflammatory responses by fractalkine signaling in microglia

Koichi Inoue1, Hiroyuki Morimoto1, Masahiro Ohgidani1

  • 1Department of Integrative Anatomy, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Plos One
|May 21, 2021
PubMed

Insights

Delayed fractalkine (FKN) administration reduces nitric oxide production in activated microglia. This modulation of microglial response, linked to CX3CR1 receptor levels, offers therapeutic insights for neurological disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Reactive microglia play a role in neurological disorders.
  • Fractalkine (FKN/CX3CL1) signaling, via its receptor CX3CR1 on microglia, can be protective against inflammation.
  • Understanding microglial responses to FKN is crucial for developing therapeutic strategies for neurological diseases.

Purpose of the Study:

  • To investigate the therapeutic potential of delayed fractalkine (FKN) administration on activated microglia.
  • To examine the impact of FKN on microglial activation markers, including nitric oxide (NO) production and CX3CR1 expression.

Main Methods:

  • Primary murine microglia and BV-2 microglial cell lines were used.
  • Lipopolysaccharide (LPS) was administered to induce microglial activation.
  • Fractalkine (FKN) was administered at different time points relative to LPS.
  • Nitric oxide (NO) production, inducible nitric oxide synthase (iNOS) expression, cell morphology, migration, proliferation, and CX3CR1 mRNA levels were assessed.

Main Results:

  • Delayed FKN administration (4 hours post-LPS) reduced NO production without altering iNOS expression.
  • Cell morphology, migration, and proliferation remained unchanged with delayed FKN treatment.
  • LPS decreased CX3CR1 mRNA levels, which was restored by CX3CR1 overexpression, leading to reduced NO production.
  • ATP and ethanol also decreased CX3CR1 mRNA.

Conclusions:

  • Delayed FKN administration can modulate LPS-induced microglial activation, specifically reducing NO production.
  • Inflammatory stimuli can attenuate FKN signaling by reducing CX3CR1 expression, thereby modulating microglial inflammatory responses.